GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (NSE:CONCORDBIO) » Definitions » Cash Flow for Dividends

Concord Biotech (NSE:CONCORDBIO) Cash Flow for Dividends : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Cash Flow for Dividends?

Concord Biotech's cash flow for dividends for the three months ended in Dec. 2024 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Concord Biotech's annual payment of dividends declined from Mar. 2022 (₹-705 Mil) to Mar. 2023 (₹-536 Mil) but then increased from Mar. 2023 (₹-536 Mil) to Mar. 2024 (₹-715 Mil).


Concord Biotech Cash Flow for Dividends Historical Data

The historical data trend for Concord Biotech's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Cash Flow for Dividends Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Dividends
-805.45 -57.06 -705.21 -535.64 -714.53

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Concord Biotech Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Biotech Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Biotech Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines